Skip to main content

Table 2 The anticancer effect of HCPT-loaded nanoparticles in the treatment of xenografts

From: Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect

 

Lovo cells xenograft

Tca8113 cells xenograft

 

TDT (d)

IR (%)

TV(cm3)

TDT (d)

IR (%)

TV(cm3)

Blank control

3.0

0

4.336 ± 0.485

3.5

0

3.888 ± 0.547

PEG-PBLG

2.9

0

4.206 ± 0.308*

3.6

0

3.944 ± 0.179*

HCPT

4.3

70.0%

1.299 ± 0.082#

4.5

59.8%

1.564 ± 0.286#

HCPT/PEG-PBLG

4.9

83.8%

0.701 ± 0.067

4.9

85.6%

0.559 ± 0.062

  1. TDT: tumor doubling time; IR: inhibition rate; TV: tumor volume at day 21 for Lovo cells xenograft or day 34 for Tca8113 cells xenograft
  2. *: compared with blank: P = 0.451 or 0.765(front:Lovo xenograft; the latter:Tca8113 xenograft); #: compared with blank: P = 0.000;
  3. §: Compared with HCPT: P = 0.002 or 0.000(front:Lovo xenograft; the latter:Tca8113 xenograft)